Breast MRI
Showing 1 - 25 of >10,000
Breast Cancer Female Trial (State-Trait Anxiety Inventory (STAI))
Not yet recruiting
- Breast Cancer Female
- State-Trait Anxiety Inventory (STAI)
- (no location specified)
Aug 18, 2023
Breast Tumors, Breast Cancer Trial in Busan, Seoul (Breast MRI for Breast Cancer Detection)
Not yet recruiting
- Breast Neoplasms
- Breast Cancer
- Breast MRI for Breast Cancer Detection
-
Busan, BusanJin-Gu, Korea, Republic of
- +3 more
Apr 2, 2023
Breast Benign Tumor, Breast Malignant Tumor Trial in Birmingham (Standard of Care (SOC) gadolinium Breast MRI, reduced 1/4 dose
Active, not recruiting
- Breast Benign Tumor
- Breast Malignant Tumor
- Standard of Care (SOC) gadolinium Breast MRI
- reduced 1/4 dose gadolinium Breast MRI with Artificial Intelligence (AI) to aid in evaluation.
-
Birmingham, AlabamaThe Kirklin Clinic
Dec 12, 2022
Breast Cancer Trial in Aarhus, Viborg (Breast MRI, standard breast imaging)
Recruiting
- Breast Cancer
- Breast MRI
- standard breast imaging
-
Aarhus, Denmark
- +1 more
Apr 11, 2023
Breast Cancer Trial in Shanghai
Not yet recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaFudan university Shanghai Cancer Center
May 29, 2023
Breast Cancer Trial (Patient nudge, Provider nudge)
Not yet recruiting
- Breast Cancer
- Patient nudge
- Provider nudge
- (no location specified)
Mar 28, 2023
CESM ABMR Breast Cancer Screening Trial
Completed
- Breast Cancer Screening
- Contrast-enhanced Spectral Mammography (CESM)
-
Seattle, WashingtonSeattle Cancer Care Alliance
Jan 4, 2023
Abbreviated Breast MRI After BCT
Active, not recruiting
- Breast Neoplasms
- Carcinoma, Intraductal, Noninfiltrating
-
Philadelphia, PennsylvaniaUPenn
Nov 18, 2022
Breast Cancer, Ductal Carcinoma in Situ Trial in Basking Ridge, Commack, New York (MRI)
Active, not recruiting
- Breast Cancer
- Ductal Carcinoma in Situ
- MRI
-
Basking Ridge, New Jersey
- +2 more
Nov 7, 2022
Breast Cancer Female Trial (Supine MRI)
Not yet recruiting
- Breast Cancer Female
- Supine MRI
- (no location specified)
Feb 18, 2022
SURPASS Retrospective Study
Completed
- Breast Cancer
- +3 more
- Sentinel lymph node biopsy followed by axillary lymph node dissection
- (no location specified)
Mar 20, 2023
Pathologic Response in Breast Cancer With Neoadjuvent
Not yet recruiting
- Role of MRI in Evaluation of Breast Cancer
- MRI
- (no location specified)
Mar 20, 2022
Breast Cancer Trial in Worcester (Breast MRI)
Not yet recruiting
- Breast Cancer
- Breast MRI
-
Worcester, MassachusettsUMass Medical School
Jul 21, 2023
Patients Who Had Breast Cancer With Dense Breast Tissue
Not yet recruiting
- Breast Cancer
- Questionnaire/Interview
-
Houston, TexasMD Anderson Cancer Center
Nov 7, 2023
Breast Cancer Trial in Stockholm (AI selection for supplemental breast MRI)
Recruiting
- Breast Cancer
- AI selection for supplemental breast MRI
-
Stockholm, SwedenKarolinska University Hospital
Aug 18, 2022
Breast Cancer Trial in Ansan (MRI)
Completed
- Breast Cancer
- MRI
-
Ansan, Korea, Republic ofBo Kyoung Seo
Oct 18, 2023
Breast Cancer Trial in United States (MRI Biopsy)
Recruiting
- Breast Cancer
- MRI Biopsy
-
Basking Ridge, New Jersey
- +6 more
Nov 23, 2022
New Mammographic Techniques Versus MRI in Assessment of Breast
Completed
- Breast Diseases
- contrast enhanced digital mammography, tomosyntheis and MRI
- (no location specified)
Oct 16, 2023
Breast Cancer Trial in Ansan (MRI)
Completed
- Breast Cancer
- MRI
-
Ansan, Korea, Republic ofBo Kyoung Seo
Oct 23, 2023
Cancer Predictive Score on Breast MRI
Enrolling by invitation
- Breast Cancer
-
Montpellier, FranceUhmontpellier
Jan 10, 2022
Breast MRI Utilization Among Patients at Elevated Risk
Active, not recruiting
- Breast Cancer
- Self-Report Survey
- Qualitative Interviews
-
Washington, District of Columbia
- +1 more
May 27, 2022
MRI Characterization of Mammographically Detected DCIS
Recruiting
- Breast Cancer, Stage 0
- Breast MRI
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 21, 2022
Breast Tumors, Breast Diseases, Breast Fibroadenoma Trial in Chicago (Abbreviated MRI protocol: initial experience with Dotarem®
Recruiting
- Breast Neoplasms
- +3 more
- Abbreviated MRI protocol: initial experience with Dotarem® (Gadoterate Meglumine)
-
Chicago, IllinoisUniversity of Chicago Medicine
Dec 21, 2022
Breast Cancer Diagnosis Trial in Erlangen, Groningen, Leiden (Injection of contrast enhancing agent Gadovist for MRI
Not yet recruiting
- Breast Cancer Diagnosis
- Injection of contrast enhancing agent Gadovist for MRI investigation
- Injection of contrast enhancing agent Imeron for B-CT investigation
-
Erlangen, Germany
- +2 more
Aug 2, 2023